Cutiss Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 29
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $5.92M
Latest Deal Amount
  • Investors
  • 10

Cutiss General Information

Description

Developer of customized skin grafts intended to help in skin transplantation. The company's grafts are expanded in vitro and thereafter used in combination with a hydrogel to create a dermo-epidermal skin and considerably reduce or even avoids further corrective interventions, allowing for considerable savings, enabling patients to get treated from affected skin or damaged skin.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Medical Supplies
Primary Office
  • Grabenstrasse 11
  • 8952 Schlieren
  • Switzerland
+41 044 000 00 00

Cutiss Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cutiss Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 16-Dec-2020 $5.92M 000.00 000.00 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series B) 29-Jun-2020 000.00 000.00 000.00 Completed Clinical Trials - Phase 2
6. Accelerator/Incubator 07-Sep-2018 0000 Completed Clinical Trials - Phase 2
5. Early Stage VC (Series A) 27-Jun-2018 000.00 0000 000.00 Completed Clinical Trials - Phase 2
4. Grant 01-Jan-2018 00.000 00.000 Completed Clinical Trials - Phase 2
3. Seed Round 11-Sep-2017 00.000 00.000 Completed Clinical Trials - Phase 2
2. Accelerator/Incubator Completed Clinical Trials - Phase 2
1. Grant 15-Jun-2015 $64.3K Completed Clinical Trials - Phase 2
To view Cutiss’s complete valuation and funding history, request access »

Cutiss Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series B 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series B 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series A 390,600 $0.111146 $27.79 $27.79 1x $27.79 15.18%
Series A 53,496 $0.111146 $22.23 $22.23 1x $22.23 2.08%
To view Cutiss’s complete cap table history, request access »

Cutiss Executive Team (8)

Name Title Board Seat Contact Info
Daniela Marino Ph.D Co-Founder, Chief Executive Officer and Board Member
Kathi Mujynya Ludunge Chief Operation Officer
Fabienne Hartmann-Fritsch Co-Founder & Chief Clinical Officer
Vincent Ronfard Chief Innovation Officer
Ernst Reichmann Ph.D Co-Founder & Board Member
You’re viewing 5 of 8 executive team members. Get the full list »

Cutiss Board Members (6)

Name Representing Role Since
Daniela Marino Ph.D Cutiss Co-Founder, Chief Executive Officer and Board Member 000 0000
Ernst Reichmann Ph.D Cutiss Co-Founder & Board Member 000 0000
Gerard Ber Self Board Member 000 0000
Giammaria Giuliani Giuliani Board Member 000 0000
Martin Meuli Cutiss Co-Founder & President of the Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Cutiss Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cutiss Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GISEV Family Office Family Office Minority 000 0000 000000 0
Wyss Zurich Accelerator/Incubator Minority 000 0000 000000 0
Giuliani Corporation Minority 000 0000 000000 0
Yellowstone Holdings Corporation Minority 000 0000 000000 0
Zürcher Kantonalbank Corporation Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »